The role of antigen-presenting cells in the pathogenesis of COVID-19.

Authors:
Farzi R; Aghbash PS; Eslami N; Azadi A; Shamekh A and 3 more

Journal:
Pathol Res Pract

Publication Year: 2022

DOI:
10.1016/j.prp.2022.153848

PMCID:
PMC8941975

PMID:
35338971

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Pathol Res Pract

Abbreviation: Pathol Res Pract

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pathology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Complement and complement regulatory proteins are upregulated in lungs of COVID-19 patients.
Ge X; Yu Z; Guo X and 7 more (2023) - Transparency Score: 3/6
Autoimmune mucocutaneous blistering diseases after SARS-Cov-2 vaccination: A Case report of Pemphig…
Calabria E; Canfora F; Mascolo M and 3 more (2022) - Transparency Score: 2/6
Biobanking in times of crisis - The COVID-19 Autopsy and Biosample Registry Baden-Wuerttemberg.
Domke LM; Klein IM; Hartmann L and 7 more (2022) - Transparency Score: 3/6
Cell tropism and viral clearance during SARS-CoV-2 lung infection.
Schwab C; Domke LM; Rose F and 3 more (2022) - Transparency Score: 3/6
Pathological effects of SARS-CoV-2 on hematological and immunological cells: Alterations in count, …
Ahmadi E; Bagherpour Z; Zarei E and 1 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest The authors declared that there is no conflict of interest related to this study."

Evidence found in paper:

"Funding We did not support a specific source of funding for this article."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025